4-11-09 | HSE and H1N1 Vaccination

04 November 2009
print version share on facebook

The HSE recommends that certain patients in 'high risk groups' receive the H1N1 vaccine. This includes some people with epilepsy as follows;

  • Pregnant women.
  • People with history of epilepsy with other co-morbidities such as an intellectual disability.
  • People whose epilepsy is not fully controlled who experience habitual seizures.
  • People who have a history of having breakthrough seizures when they are experiencing a high temperature, should consider receiving the vaccination.
  • People whose seizures are well controlled without any other co-morbidity should await further advice, as will be given to the general population.

Other high risk groups as defined by the HSE are;

"People who have: chronic lung, heart, kidney, liver, or NEUROLOGICAL
DISEASE people whose immune system is reduced by disease or medications; people with diabetes mellitus; people aged 65 years and older; children under 5 (children under 2 are at particular risk of influenza); people on medication for asthma, severely obese people (body mass index more than 40), pregnant women and people with haemoglobinopathies".

Patients receiving the vaccination should be advised to administer paracetamol two hours prior to the vaccination and as per the
recommended daily dose for two days after the vaccination. Patients should also be advised to increase their fluid intake

For the moment we do not have sufficient advice on which preparation of the vaccine patients should receive.

For more information contact the HSE information line on : 1850 24 1850 or
log on to www.swineflu.ie 


web design by ionic